stem_cells

It is thought that PD may be the first disease to be amenable to treatment using stem cell transplantation. Factors that support this notion include the knowledge of the specific cell type (DA neurons) needed to relieve the symptoms of the disease. In addition, several laboratories have been successful in developing methods to induce embryonic stem cells to differentiate into cells with many of the functions of DA neurons.

Such information is critical for scientists to be able to grow large numbers of unspecialized stem cells in the laboratory for further experimentation. Stem cells can give rise to specialized cells. When unspecialized stem cells give rise to specialized cells, the process is called differentiation. Scientists are just beginning to understand the signals inside and outside cells that trigger stem cell differentiation.

The primer includes information about stem cells derived from the embryo and adult. Much of the information included here is about stem cells derived from human tissues, but some studies of animal-derived stem cells are also described. Stem cells differ from other kinds of cells in the body. All stem cells � regardless of their source � have three general properties: they are capable of dividing and renewing themselves for long periods; they are unspecialized; and they can give rise to specialized cell types. Stem Cells for the Future Treatment of Parkinson's Disease Parkinson's disease (PD) is a very common neurodegenerative disorder that affects more than 2% of the population over 65 years of age.